Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03924895
Brief Title: Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

First Submitted : April 22, 2019
First Submitted that Met QC Criteria : April 22, 2019
First Posted : April 23, 2019

Last Update Submitted that Met QC Criteria : July 30, 2021
Last Update Posted : August 2, 2021